Why DermaSensor won
DermaSensor is recognized as the 2026 Best Company in AI Early Cancer Detection at the AI Horizon Awards for its AI-powered spectroscopy that assesses skin lesions for skin cancer risk in seconds.
About DermaSensor
DermaSensor Inc. makes a handheld, non-invasive device that combines elastic scattering spectroscopy with a machine-learning algorithm to give physicians an immediate, objective skin cancer risk assessment for lesions suggestive of melanoma, basal cell carcinoma or squamous cell carcinoma. The device received FDA De Novo clearance in January 2024, the first AI-enabled skin cancer assessment device for primary care to do so, and a Class IIb CE Mark in June 2026. The company was founded in 2009 by Maurice Ferre and Chris Dewey and is led by co-founder and CEO Cody Simmons.
About the AI Horizon Awards
The AI Horizon Awards recognize companies and products doing outstanding work in artificial intelligence, from AI agents and foundation models to healthcare, robotics and security. Winners are recognized for innovation, real-world impact and leadership in AI.
AWARDS
Show your Winner Badge
Add the official winner badge to your website, press page or email signature. It links back to this page so anyone can confirm the award.

Show your Winner Card
Share the full winner card on LinkedIn, your blog or your press page. Download the image, or copy the code to show it on your site with a link back to this page.
Download Winner Card